{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:08:52Z","timestamp":1740107332179,"version":"3.37.3"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00415-019-09205-3","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T22:18:07Z","timestamp":1548627487000},"page":"777-779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Charles Bonnet syndrome in Leber\u2019s hereditary optic neuropathy"],"prefix":"10.1007","volume":"266","author":[{"given":"Hana","family":"Kolarova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia B.","family":"Catarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Priglinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2805-4652","authenticated-orcid":false,"given":"Thomas","family":"Klopstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"9205_CR1","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1097\/OPX.0000000000000959","volume":"93","author":"L Pang","year":"2016","unstructured":"Pang L (2016) Hallucinations experienced by visually impaired: Charles Bonnet syndrome. Optom Vis Sci 93:1466\u20131478","journal-title":"Optom Vis Sci"},{"key":"9205_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.survophthal.2006.10.007","volume":"52","author":"TR Hedges","year":"2007","unstructured":"Hedges TR (2007) Charles Bonnet, his life, and his syndrome. Surv Ophthalmol 52:111\u2013114","journal-title":"Surv Ophthalmol"},{"key":"9205_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.rpsm.2013.12.002","volume":"7","author":"E Santos-Bueso","year":"2014","unstructured":"Santos-Bueso E, Saenz-Frances F, Porta-Etessam J, Garcia-Sanchez J (2014) Charles Bonnet syndrome triggered by brimonidine in a patient with Leber\u2019s hereditary optic neuropathy. Rev Psiquiatr Salud Ment 7:152\u2013153","journal-title":"Rev Psiquiatr Salud Ment"},{"key":"9205_CR4","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/brain\/123.10.2055","volume":"123","author":"AM Santhouse","year":"2000","unstructured":"Santhouse AM, Howard RJ, ffytche DH (2000) Visual hallucinatory syndromes and the anatomy of the visual brain. Brain 123:2055\u20132064","journal-title":"Brain"},{"key":"9205_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10633-010-9241-2","volume":"121","author":"PY Sacai","year":"2010","unstructured":"Sacai PY, Salomao SR, Carelli V et al (2010) Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber\u2019s hereditary optic neuropathy. Doc Ophthalmol 121:147\u2013154","journal-title":"Doc Ophthalmol"},{"key":"9205_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S0039-6257(02)00414-9","volume":"48","author":"GJ Menon","year":"2003","unstructured":"Menon GJ, Rahman I, Menon SJ, Dutton GN (2003) Complex visual hallucinations in the visually impaired: the Charles Bonnet syndrome. Surv Ophthalmol 48:58\u201372","journal-title":"Surv Ophthalmol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09205-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09205-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09205-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T19:10:53Z","timestamp":1580152253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09205-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["9205"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09205-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"27 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. Priglinger and Klopstock have received research grants from Santhera Pharmaceuticals and from GenSight Biologics. Drs. Catarino and Klopstock received travel costs from Santhera Pharmaceuticals and from GenSight Biologics. Dr. Kolarova received speaker and consulting honoraria from Santhera Pharmaceuticals. Dr. Klopstock received speaker and consulting honoraria from Santhera Pharmaceuticals and from GenSight Biologics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The data presented here were collected in the context of standard medical care. Beyond, phenotyping of patients with mitochondrial disorders and analysis of the respective data has been approved by the ethics committee of the University of Munich in the context of the German network for mitochondrial disorders (mitoNET) and has, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}